[YMAB] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
13-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -32.63%
YoY- -109.36%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -40,393 -26,179 -23,136 -23,922 -18,036 -15,934 -14,060 102.22%
Tax 0 0 -79 0 0 -19 0 -
NP -40,393 -26,179 -23,136 -23,922 -18,036 -15,934 -14,060 102.22%
Tax Rate - - - - - - - -
Total Cost 40,393 26,179 23,136 23,922 18,036 15,934 14,060 102.22%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.01 -0.66 -0.61 -0.70 -0.53 -0.47 -0.41 82.50%
EPS Diluted -1.01 -0.66 -0.58 -0.70 -0.53 -0.47 -0.41 82.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.